These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 7609502)

  • 1. FDA guidelines on trough: peak ratios in the evaluation of antihypertensive agents. United States Food and Drug Administration.
    Meredith PA; Elliott HL
    J Cardiovasc Pharmacol; 1994; 23 Suppl 5():S26-30. PubMed ID: 7609502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New FDA guidelines on the treatment of hypertension: comparison of different therapeutic classes according to trough/peak blood pressure responses.
    Meredith PA
    Arch Mal Coeur Vaiss; 1994 Nov; 87(11):1423-9. PubMed ID: 7771888
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood pressure variability: clinical implications and effects of antihypertensive treatment.
    Parati G; Ravogli A; Frattola A; Groppelli A; Ulian L; Santucciu C; Mancia G
    J Hypertens Suppl; 1994 Jul; 12(5):S35-40. PubMed ID: 7965285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trough: peak ratio: the rationale behind the United States Food and Drug Administration recommendations.
    Lipicky RJ
    J Hypertens Suppl; 1994 Nov; 12(8):S17-8; discussion S18-9. PubMed ID: 7707150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antihypertensive effect of drugs: statistical distribution of the trough-to-peak ratio.
    Chi VX; Chau NP
    Biometrics; 1996 Mar; 52(1):286-90. PubMed ID: 8934597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of trough to peak efficacy in the evaluation of antihypertensive therapy.
    Meredith PA
    J Hypertens Suppl; 1998 Jan; 16(1):S59-64. PubMed ID: 9534099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Problems in evaluating the long-term effect of antihypertensive drugs: once again: the trough/peak ratio].
    Hitzenberger G
    Wien Med Wochenschr; 1997; 147(14):333-5. PubMed ID: 9381727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The trough/peak ratio].
    Salvetti A; Virdis A
    Ann Ital Med Int; 1995 Oct; 10 Suppl():91S-95S. PubMed ID: 8562276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trough and peak effects of a single daily dose of nifedipine gastrointestinal therapeutic system (GITS) as assessed by ambulatory blood pressure monitoring. Italian Nifedipine GITS Study Group.
    Zanchetti A
    J Hypertens Suppl; 1994 Jul; 12(5):S23-7. PubMed ID: 7965282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Practical relevance of the 24-hour trough: peak ratio of antihypertensive drugs.
    Zannad F
    J Hypertens Suppl; 1995 Aug; 13(2):S109-12. PubMed ID: 8576780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The United States Food and Drug Administration guidelines on ambulatory blood pressure monitoring.
    Lipicky R
    J Hypertens Suppl; 1991 Dec; 9(8):S59. PubMed ID: 1795204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Self-measurement of blood pressure at home to evaluate drug effects by the trough: peak ratio.
    Ménard J; Chatellier G; Day M; Vaur L
    J Hypertens Suppl; 1994 Nov; 12(8):S21-5. PubMed ID: 7707151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changing the timing of antihypertensive therapy to reduce nocturnal blood pressure in CKD: an 8-week uncontrolled trial.
    Minutolo R; Gabbai FB; Borrelli S; Scigliano R; Trucillo P; Baldanza D; Laurino S; Mascia S; Conte G; De Nicola L
    Am J Kidney Dis; 2007 Dec; 50(6):908-17. PubMed ID: 18037091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. What are the approaches for evaluating antihypertensive treatment by 24 h ambulatory blood pressure monitoring?
    Neutel JM; Smith DH; Weber MA
    Blood Press Monit; 1999; 4 Suppl 2():S23-8. PubMed ID: 10822419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trough/peak ratios for antihypertensive agents. The issues in perspective.
    Meredith PA
    Drugs; 1994 Nov; 48(5):662-6. PubMed ID: 7530624
    [No Abstract]   [Full Text] [Related]  

  • 16. Second-generation calcium antagonists and ambulatory blood pressure monitoring.
    Mallion JM; Baguet JP; Boutelant S; Tremel F; Siché JP; de Gaudemaris R
    J Cardiovasc Pharmacol; 1995; 25 Suppl 3():S17-22. PubMed ID: 8852540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antihypertensive treatment and trough: peak ratio: general considerations.
    Meredith PA; Elliott HL
    J Hypertens Suppl; 1994 Nov; 12(8):S79-82; discussion S83. PubMed ID: 7707161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trough:peak ratio of the blood pressure response to dihydropyridine calcium antagonists. Italian Nifedipine GITS Study Group.
    Zanchetti A
    J Hypertens Suppl; 1994 Nov; 12(8):S97-106. PubMed ID: 7707165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trough: peak ratio and twenty-four-hour blood pressure control.
    Elliott HL
    J Hypertens Suppl; 1994 Jul; 12(5):S29-33. PubMed ID: 7965283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Evaluation of the effectiveness of antihypertensive therapy. Is the trough-peak ratio the determining factor?].
    Widimský J
    Vnitr Lek; 1996 Feb; 42(2):102-5. PubMed ID: 8686181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.